Fillif Peg 6mg Injection

Fillif Peg 6mg Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates bone marrow to produce white blood cells. These cells protect the body against infections.

Fillif Peg 6mg Injection is given as an injection by a qualified medical professional. You should continue to take as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. You might be asked for regular tests done to check the number of blood cells in your blood and your bone density level while you are taking this medicine.

The most common side effects of this medicine include bone pain, joint pain, headache, nausea, and muscle pain. Other than this, pain or redness at the site of injection is common. But, inform your doctor if you notice a lump, swelling, or bruising that does not go away. It might not prevent you from all kinds of infection, hence inform your doctor if you notice fever, chills, shortness of breath, sore throat, and swelling around the face or neck.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You must avoid driving or attention-seeking activity if you experience dizziness after taking this medicine.

• Prevention of Infections after chemotherapy

Prevention of Infections after chemotherapy
Fillif Peg 6mg Injection increases the production of white blood cells by stimulating the immune system in our body. White blood cells are those cells that help us to fight infections. This medicine is really effective and must be used under medical supervision. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Pegstim

• Bone pain
• Joint pain
• Headache
• Nausea
• Low blood platelets
• Muscle pain
• Back pain
• Pain in extremities
• Injection site pain

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Fillif Peg 6mg Injection is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections. .

• Fillif Peg 6mg Injection reduces the risk of infection in people treated with chemotherapy.
• It is usually given as a daily injection into the tissue just under the skin or into the vein.
• You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
• Store it in the refrigerator, protect it from light, and don't shake it.
• For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
• Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
• Use caution while driving or doing anything that requires concentration as Fillif Peg 6mg Injection may cause dizziness.
• Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment with this medicine.
• Stop taking Fillif Peg 6mg Injection and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.

Masters SB. Agents Used in Anemias; Hematopoetic Growth Factors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 581.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1074-75.

Pegfilgrastim. Cambridge, UK: Amgen Ltd.; 2002 [revised Sep. 2018]. [Accessed 28 Jan 2019] (online) Available from:

Medscape. Pegfilgrastim. [Accessed 26 Mar. 2019] (online) Available from: